Journal: Gene Therapy
Article Title: Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCs
doi: 10.1038/s41434-025-00587-w
Figure Lengend Snippet: A Schematic representation of the different WT or cytoplasmic domain-modified viral envelope glycoproteins (gp) for pseudotyping of LVs. MLV, murine leukemia virus; HERV-W, human endogenous retrovirus V-W, HERV-Cyt16, HERV- Cyt31: cytoplasmic tail deletion mutants, HERVTR, HERV gp mutant carrying the cytoplasmic tail and R-peptide of the MLV gp; HERVRLess, HERV gp mutant lacking the R-peptide, BaEV baboon endogenous retrovirus gp, BaEVTR, BaEV gp carrying the cytoplasmic tail and R-peptide of the MLV gp, BaEVRless is a BaEV gp mutant lacking the R-peptide. B Titer of the different vector pseudotypes carrying a GFP reporter gene determined on 293 T cells by serial vector dilutions. Titer was analysed by FACS at day 3 post-transduction for GFP expression (IU/ml; mean ± SD; n = 6; two-way Anova, ** p < 0.01, *** p < 0.001,**** p < 0.0001).
Article Snippet: Peripheral blood (PB) T lymphocytes were prestimulated for 3 days with T cell human hCD3/hCD28 TransAct beads (Miltenyi Biotec; #130-111-160,) supplemented with IL-2 (100 ng/ml) (Miltenyi Biotec; #130-097-743,) in RPMI or were prestimulated with recombinant 10 ng/mL human rIL-7 (rhIL-7; Miltenyi Biotec, #130-093-937) and 10 ng/ml rhIL-15 (Miltenyi Biotec 130-093-955,) for 3 days.
Techniques: Modification, Virus, Mutagenesis, Plasmid Preparation, Transduction, Expressing